Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease

By Stefan Blankenberg, H. Rupprecht, O. Poirier, C. Bickel, M. Smieja, G. Hafner, Jürgen Meyer, F. Cambien, L. Tiret. Circulation, 2003

757 citations recorded by the source corpus.

Subfields: Cancer Research, Cardiology and Cardiovascular Medicine, Immunology

View Paper: https://www.semanticscholar.org/paper/9a99836630e7bdc4bfea2ad2cf7d7741aec87bef

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Yabluchanskiy
2. Yonggang Ma
3. M. Lindsey
4. Michael E. Hall
5. R. Iyer

Citations in the corpus

• Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. (2018, neutral): “Also, in a study of 1127 patients, higher serum levels of MMP-9 were associated with the T allele, but did not predict cardiovascular death (Blankenberg et al., 2003).”
• Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. (2013, background): “An increase in systemic MMP-9 levels is highly correlated with cardiovascular mortality in patients with atherosclerosis (7).”